China's Tsingke Biotechnology secures $57m in Series B round
The firm will use the proceeds to upgrade its technology platform as well as for team expansion.
Source: dealstreetasia.com
Stay updated with breaking news from Beijing Based Tsingke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The firm will use the proceeds to upgrade its technology platform as well as for team expansion.